Genetic analysis and clinical investigation of a pedigree with multiple endocrine neoplasia type 2A: A case report

Zou,Hong‑Jin; Li,Yu‑Shu; Shan,Zhong‑Yan

doi:10.3892/ol.2016.5028

Genetic analysis and clinical investigation of a pedigree with multiple endocrine neoplasia type 2A: A case report

Authors:
- Hong‑Jin Zou
- Yu‑Shu Li
- Zhong‑Yan Shan
View Affiliations

Affiliations: Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: August 16, 2016 https://doi.org/10.3892/ol.2016.5028
Pages: 2657-2659

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple endocrine neoplasia 2A (MEN2A) is characterized by the coexistence of tumors that involve two or more endocrine glands within the same patient, and is defined as the occurrence of medullary thyroid carcinoma in association with pheochromocytoma (PHEO) and parathyroid tumors or hyperparathyroidism. The pathogenesis of MEN2A is due to the mutation of a tyrosine kinase receptor that is encoded by the rearrangement during transfection (RET) proto‑oncogene. The mutation often occurs in exon 10q11.2. The present study reports the case of a 73‑year‑old man with severe hypercalcemia, bilateral adrenal PHEO and a thyroid nodule. A genetic panel was obtained, and the RET mutation was indicated. The pedigree of the patient was also studied. Genetic testing of the patient's son indicated heterozygosity for the same mutation at codon 634. The first symptom of the two patients was PHEO, which is uncommon. In addition, varied phenotypes were identified in the two patients. In the present study, the association between the phenotypic variation of the RET gene and the occurrence of MEN2A is discussed.

View Figures

View References

1	Steiner AL, Goodman AD and Powers SR: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia, type 2. Medicine (Baltimore). 47:371–409. 1968. View Article : Google Scholar : PubMed/NCBI
2	Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS and Wells SA: Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity. Br J Surg. 73:278–281. 1986. View Article : Google Scholar : PubMed/NCBI
3	Ezzat T, Paramesawaran R, Phillips B and Sadler G: MEN 2 syndrome masquerading as MEN 1. Ann R Coll Surg Engl. 94:e206–e207. 2012. View Article : Google Scholar : PubMed/NCBI
4	Muzannara MA, Tawfeeq N, Nasir M, Al Harbi MK, Geldhof G and Dimitriou V: Vaginal delivery in a patient with pheochromocytoma, medullary thyroid cancer, and primary hyperparathyroidism (multiple endocrine neoplasia type 2A, Sipple's syndrome). Saudi J Anaesth. 8:437–439. 2014. View Article : Google Scholar : PubMed/NCBI
5	Lau GS, Lang BH, Lo CY, Tso A, Garcia-Barcelo MM, Tam PK and Lam KS: Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing. Hong Kong Med J. 15:326–331. 2009.PubMed/NCBI
6	American Thyroid Association Guidelines Task Force. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M and Wells SA Jr: Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid. 19:565–612. 2009. View Article : Google Scholar : PubMed/NCBI
7	Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, et al: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 86:5658–5671. 2001. View Article : Google Scholar : PubMed/NCBI
8	Moley JF: The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes. Annu Rev Med. 48:409–420. 1997. View Article : Google Scholar : PubMed/NCBI
9	Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T and Sakurai A: MEN Consortium of Japan: High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Eur J endocrinol. 168:683–687. 2013. View Article : Google Scholar : PubMed/NCBI
10	Rowland KJ, Chernock RD and Moley JF: Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: Implications for screening. J Surg Oncol. 108:203–206. 2013. View Article : Google Scholar : PubMed/NCBI
11	Krampitz GW and Norton JA: RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer. 120:1920–1931. 2014. View Article : Google Scholar : PubMed/NCBI
12	Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458–460. 1993. View Article : Google Scholar : PubMed/NCBI
13	Mathew CG, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ and Ponder BA: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature. 328:524–526. 1987. View Article : Google Scholar : PubMed/NCBI
14	Tessitore A, Sinisi AA, Pasquali D, Cardone M, Vitale D, Bellastella A and Colantuoni V: A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. J Clin Endocrinol Metab. 84:3522–3527. 1999. View Article : Google Scholar : PubMed/NCBI
15	Qi X-P, Ma J-M, Du Z-F, Ying R-B, Fei J, Jin HY, Han JS, Wang JQ, Chen XL, Chen CY, et al: RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family. PLoS One. 6:e203532011. View Article : Google Scholar : PubMed/NCBI
16	Gosnell JE, Sywak MS, Sidhu SB, Gough IR, Learoyd DL, Robinson BG and Delbridge LW: New era: Prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ J Surg. 76:586–590. 2006. View Article : Google Scholar : PubMed/NCBI
17	Balachandran K, Kamalanathan S, Gopalakrishnan S and Murugananadham K: Multiple endocrine neoplasia 2B: Delayed presentation, rapid diagnosis. BMJ Case Rep. 2013:bcr20130091852013.PubMed/NCBI
18	Cui Q, Wang W, Fu Z, Shao X, Zhang Z, Zhang M, Ju X, Wang K, Chen J and Zhou H: Integrated DNA-based/biochemical screening for early diagnosis of multiple endocrine neoplasia type 2A (MEN2A). J Biomed Res. 27:145–150. 2013. View Article : Google Scholar : PubMed/NCBI